Deferred Tax Assets, Operating Loss Carryforwards of Yubo International Biotech Ltd from 31 Dec 2023 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Yubo International Biotech Ltd quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 Dec 2023 to 30 Sep 2024.
  • Yubo International Biotech Ltd Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 30 Sep 2024 was $1,448,377.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)

Yubo International Biotech Ltd Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $1,448,377 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $1,293,198 30 Jun 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 $1,149,861 31 Mar 2024 10-Q 20 May 2024 2024 Q1
Q4 2023 $1,051,235 31 Dec 2023 10-Q 13 Nov 2024 2024 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.